. "Tomala, Jakub" . "[EF86896A6C8F]" . . . "Ulbrich, Karel" . "000259724800097" . "Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice"@en . "4"^^ . "Tokyo" . . "2008-10-05+02:00"^^ . "\u0158\u00EDhov\u00E1, Blanka" . . "doxorubicin; IL-2/anti-IL-2mAb; melanoma"@en . "Na\u0161\u00EDm c\u00EDlem bylo bl\u00ED\u017Ee objasnit mechanismus \u00FA\u010Dinku imunokomplex\u016F IL-2/anti-IL-2 protil\u00E1tky a zhodnotit jejich in vivo potenci\u00E1l v kombinaci s polymern\u00EDm doxorubicinov\u00FDm konjug\u00E1tem na bun\u011B\u010Dn\u00E9 linii B16F10 melanomu"@cs . "Strohalm, Ji\u0159\u00ED" . . "1"^^ . "RIV/61388971:_____/08:00325250!RIV09-AV0-61388971" . "Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice"@en . . "KARGER" . "6"^^ . "Chmelov\u00E1, Helena" . . . . "Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice" . . . "Basel" . . . . . . . "Kov\u00E1\u0159, Marek" . . "P(1M0505), P(GP301/07/P192), Z(AV0Z40500505), Z(AV0Z50200510)" . "Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice"@en . . . "1010-4283" . . "Meeting of the International Society of Oncology and BioMarkers /36./" . "394953" . "RIV/61388971:_____/08:00325250" . "Sou\u010Dinn\u00FD l\u00E9\u010Debn\u00FD efekt imunokomplex\u016F IL-2/anti-IL-2 protil\u00E1tky a"@cs . "Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice" . "Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice" . . "Sou\u010Dinn\u00FD l\u00E9\u010Debn\u00FD efekt imunokomplex\u016F IL-2/anti-IL-2 protil\u00E1tky a"@cs .